» Articles » PMID: 21869913

Splanchnic Vein Thrombosis in the Mediterranean Area in Children

Overview
Date 2011 Aug 27
PMID 21869913
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Abdominal venous thrombosis may present as splanchnic venous thrombosis (SVT) (occlusion of portal, splenic, superior or inferior mesenteric veins) or Budd- Chiari Syndrome (BCS) (thrombosis of inferior vena cava and/or hepatic veins). The aim of this review is to report the scanty data available for SVT in the South Mediterranean area. In one Egyptian study, the possible circumstantial risk factors for portal vein thrombosis (PVT) were found in 30% of cases: 19% neonatal sepsis, 8.7% umbilical catheterization, 6% severe gastroenteritis and dehydration. Another Egyptian study concluded that hereditary thrombophilia was common in children with PVT (62.5%), the commonest being factor V Leiden mutation (FVL) (30%). Concurrence of more than one hereditary thrombophilia was not uncommon (12.5%). The first international publication on hepatic veno-occlusive disease (VOD) in Egypt was in 1965 in children who rapidly develop abdominal distention with ascites and hepatomegaly. This disease was more frequent in malnourished children coming from rural areas; infusions given at home may contain noxious substances that were hepatotoxic and infections might play a role. VOD of childhood is rarely seen nowadays. Data from South Mediterranean area are deficient and this may be attributable to reporting in local medical journals that are difficult to access. Medical societies concerned with this topic could help distribute this information.

Citing Articles

Case Report: Splanchnic Vein Thrombosis as a Complication of Necrotizing Acute Pancreatitis in a Pediatric Patient.

Figueroa-Sanchez M, Nuno-Guzman C, Alvarez-Lopez M, Ordonez-Cardenas M, Montano-Rodriguez L Front Surg. 2022; 9:747671.

PMID: 35433812 PMC: 9010654. DOI: 10.3389/fsurg.2022.747671.


Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Clark J, Adler G, Salkic N, Ciechanowicz A J Appl Genet. 2013; 54(4):441-446.

PMID: 23959593 PMC: 3825156. DOI: 10.1007/s13353-013-0166-9.

References
1.
Egesel T, Buyukasik Y, Dundar S, Gurgey A, Kirazli S, Bayraktar Y . The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol. 2000; 30(1):66-71. DOI: 10.1097/00004836-200001000-00013. View

2.
Rosendaal F . Venous thrombosis: a multicausal disease. Lancet. 1999; 353(9159):1167-73. DOI: 10.1016/s0140-6736(98)10266-0. View

3.
Bayraktar Y, Harmanci O . Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006; 12(8):1165-74. PMC: 4124424. DOI: 10.3748/wjg.v12.i8.1165. View

4.
Bilodeau M, Aubry M, Houle R, Burnes P, Ethier C . Evaluation of hepatocyte injury following partial ligation of the left portal vein. J Hepatol. 1999; 30(1):29-37. DOI: 10.1016/s0168-8278(99)80005-1. View

5.
Gauthier F . Recent concepts regarding extra-hepatic portal hypertension. Semin Pediatr Surg. 2005; 14(4):216-25. DOI: 10.1053/j.sempedsurg.2005.06.004. View